The use of artificial intelligence (AI) in drug development has been hyped up for some time now – and the COVID-19 pandemic is finally a chance for these technologies to prove their worth.
Research into drugs that could treat or prevent COVID-19 continued full steam ahead this week as the industry puts all its resources into fighting the coronavirus pandemic.
The world is waiting with bated breath for a coronavirus vaccine, which has become one of the most sought-after pharmaceutical products of the last century.
As Europe and the US mooted easing lockdown restrictions this week, pharma ramped up its testing of vaccines and antiviral drugs – but there are signs that the virus is starting to bite int
Most health conditions do not discriminate based on race, color, gender or identity. However, background and identity can make access to health treatment much more difficult.
